This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dunn, K J Articles by Blair, D G Search for Related Content PubMed PubMed Citation Articles by Dunn, K J Articles by Blair, D G

A phenotypic host range alteration determines RD114 virus restriction in feline embryonic cells.

Laboratory of Molecular Oncology, National Cancer Institute, Frederick, Maryland 21702-1201.

ABSTRACT

We have characterized the restriction mechanism for RD114 virus replication in embryonic feline cells (FeF). By comparing growth properties of the virus in FeF cells with its behavior in a fetal feline glial cell line (G355) permissive for RD114, we showed that both cell lines were readily infectible by virus grown in permissive cells and that no significant differences in viral integration or viral RNA expression could be detected. However, analysis of viral protein expression revealed differences in viral env gene processing in the two cell types. Envelope precursor pR85 was produced, but the expected processed gp70 product was detectable only in permissive (G355) cells. An envelope product of 85 kDa was packaged into virions produced by FeF cells, while virions produced by G355 cells contained the expected RD114 gp70. While the gp85 env-containing virions were infectious for permissive G355 cells, they were unable to infect FeF cells. The block to infection by the gp85-containing particles in FeF cells could be abrogated by treatment with the glycosylation inhibitor tunicamycin. Our results indicate that restriction of RD114 virus involves a novel mechanism dependent on two factors: altered glycosylation of the envelope to a gp85 form and an altered RD114 receptor in FeF cells.

This article has been cited by other articles:

• Miller, A. D., Bergholz, U., Ziegler, M., Stocking, C. (2008). Identification of the Myelin Protein Plasmolipin as the Cell Entry Receptor for Mus caroli Endogenous Retrovirus. J. Virol. 82: 6862-6868 [Abstract] [Full Text]  
• Manel, N., Battini, J.-L., Sitbon, M. (2005). Human T Cell Leukemia Virus Envelope Binding and Virus Entry Are Mediated by Distinct Domains of the Glucose Transporter GLUT1. J. Biol. Chem. 280: 29025-29029 [Abstract] [Full Text]  
• Dirks, C., Duh, F.-M., Rai, S. K., Lerman, M. I., Miller, A. D. (2002). Mechanism of Cell Entry and Transformation by Enzootic Nasal Tumor Virus. J. Virol. 76: 2141-2149 [Abstract] [Full Text]  
• Rai, S. K., DeMartini, J. C., Miller, A. D. (2000). Retrovirus Vectors Bearing Jaagsiekte Sheep Retrovirus Env Transduce Human Cells by Using a New Receptor Localized to Chromosome 3p21.3. J. Virol. 74: 4698-4704 [Abstract] [Full Text]  
• Dreyer, K., Pedersen, F. S., Pedersen, L. (2000). A 13-Amino-Acid Pit1-Specific Loop 4 Sequence Confers Feline Leukemia Virus Subgroup B Receptor Function upon Pit2. J. Virol. 74: 2926-2929 [Abstract] [Full Text]  
• Wolgamot, G., Miller, A. D. (1999). Replication of Mus dunni Endogenous Retrovirus Depends on Promoter Activation Followed by Enhancer Multimerization. J. Virol. 73: 9803-9809 [Abstract] [Full Text]  
• Rasko, J. E. J., Battini, J.-L., Gottschalk, R. J., Mazo, I., Miller, A. D. (1999). The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc. Natl. Acad. Sci. USA 96: 2129-2134 [Abstract] [Full Text]  
• Wolgamot, G., Bonham, L., Miller, A. D. (1998). Sequence Analysis of Mus dunni Endogenous Virus Reveals a Hybrid VL30/Gibbon Ape Leukemia Virus-Like Structure and a Distinct Envelope. J. Virol. 72: 7459-7466 [Abstract] [Full Text]